Manufacturing & Lab Equipment
Company Overview
About
O.Z.A.F. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Italy
Founded:2010
Employees:2,353
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval LINSL1
EMA · #APR-0G3IWDPE · 2020-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-2B3VKDNZ
Issued: 2020-10-22
Expires: 2025-06-25
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-9Z2TV4ZF
Issued: 2020-05-16
Expires: 2025-03-23
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-V0WXL6W1
Issued: 2020-11-24
Expires: 2025-06-09
Health Canada GMP
Health Canada
Cert #: CERT-A9U9PDMI
Issued: 2020-07-14
Expires: 2025-12-27
Loading CDMO intelligence...
Key facts about O.Z.A.F.
- O.Z.A.F. is headquartered in Italy.
- O.Z.A.F. was founded in 2010.
- O.Z.A.F. has 2,353 employees.
- O.Z.A.F.'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like O.Z.A.F.
Directory pages this company appears in, each with the full list of matching manufacturers.